MBD2 drives IPF progression through dual cell-type-specific mechanisms: epigenetic repression of the anti-fibrotic factor Erdr1 in pulmonary fibroblasts, coupled with impairment of pro-resolving M2 macrophage function. The gene discussed is MBD2; the disease is idiopathic pulmonary fibrosis.